- Home
- NTLA vs CBRL Comparison
NTLA vs CBRL Comparison
Compare NTLA & CBRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTLA
- CBRL
- Stock Information
- Founded
- NTLA 2014
- CBRL 1969
- Country
- NTLA United States
- CBRL United States
- Employees
- NTLA N/A
- CBRL N/A
- Industry
- NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CBRL Restaurants
- Sector
- NTLA Health Care
- CBRL Consumer Discretionary
- Exchange
- NTLA Nasdaq
- CBRL Nasdaq
- Market Cap
- NTLA 1.2B
- CBRL 1.3B
- IPO Year
- NTLA 2016
- CBRL N/A
- Fundamental
- Price
- NTLA $16.11
- CBRL $45.80
- Analyst Decision
- NTLA Buy
- CBRL Hold
- Analyst Count
- NTLA 20
- CBRL 8
- Target Price
- NTLA $32.30
- CBRL $52.43
- AVG Volume (30 Days)
- NTLA 4.8M
- CBRL 2.3M
- Earning Date
- NTLA 11-06-2025
- CBRL 09-17-2025
- Dividend Yield
- NTLA N/A
- CBRL 2.18%
- EPS Growth
- NTLA N/A
- CBRL 12.57
- EPS
- NTLA N/A
- CBRL 2.06
- Revenue
- NTLA $52,857,000.00
- CBRL $3,483,684,000.00
- Revenue This Year
- NTLA $8.90
- CBRL $3.37
- Revenue Next Year
- NTLA N/A
- CBRL $1.17
- P/E Ratio
- NTLA N/A
- CBRL $22.23
- Revenue Growth
- NTLA 14.99
- CBRL 0.37
- 52 Week Low
- NTLA $5.90
- CBRL $33.86
- 52 Week High
- NTLA $23.76
- CBRL $71.93
- Technical
- Relative Strength Index (RSI)
- NTLA 81.73
- CBRL 31.46
- Support Level
- NTLA $10.89
- CBRL $48.66
- Resistance Level
- NTLA $12.03
- CBRL $52.96
- Average True Range (ATR)
- NTLA 0.93
- CBRL 2.57
- MACD
- NTLA 0.34
- CBRL -0.43
- Stochastic Oscillator
- NTLA 95.09
- CBRL 2.57
About NTLA Intellia Therapeutics Inc.
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The restaurants of the company are open for breakfast, lunch, and dinner, with menus that offer home-style country food. The company generates maximum revenue from the Restaurants.